SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-18-000229
Filing Date
2018-01-08
Accepted
2018-01-08 07:11:04
Documents
3
Period of Report
2018-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_010818.htm 6-K 11209
2 EXHIBIT 99.1 exh_991.htm EX-99.1 11052
3 GRAPHIC logo.jpg GRAPHIC 4744
  Complete submission text file 0001171843-18-000229.txt   29927
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-35776 | Film No.: 18514834
SIC: 2834 Pharmaceutical Preparations